Verified Peptide ReviewLast reviewed: 28 February 2026
Compound Profile · GH Releasing
Sermorelin
Sermorelin is a 29-amino-acid GHRH analog historically used in paediatric GH evaluation and adult GH therapy.
LegalPrescriptionEvidenceModerateHuman useApproved
8.0/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Older, well-characterised GHRH analog. Effect sizes are smaller than newer alternatives but the safety record is longer.
Reality check
What this isn't
- Moderate evidence — replication still building
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full Sermorelin review
A short-acting GHRH analog.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.